Marsh & McLennan Downgraded to Hold Despite Q3 2026 Earnings Beat

Key Facts

1Marsh & McLennan exceeded revenue and EPS estimates in the third quarter of 2026.

2The company raised cost-cutting targets to $600 million by 2028 to counter margin pressures.

3The stock was downgraded to 'Hold' due to slowing underlying growth and inflation/wage pressures.

Marsh & McLennan exceeded revenue and EPS estimates in the third quarter of 2026, according to Seeking Alpha. Despite the financial beat, the stock was downgraded to 'Hold' due to slowing underlying growth and persistent inflation and wage pressures affecting operations.

The company raised its cost-cutting targets to $600 million by 2028 to counter margin erosion, as operating margins remained at 17.7% amid reinsurance weakness. MRSH closed at $186.54 on October 15, 2026, after reaching a session high of $191.04.